The First Live-Cell Based Product in The Iranian Drug List,ReColorCell

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Shahrbaf Mohammad Amin; Ataei Fashtami Leila; VOSOUGH MASSOUD

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Cell Journal (Yakhteh) Year:2023 | Volume:25 | Issue:3 Page(s): 212-214

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

The First Live-Cell Based Product in The Iranian Drug List,ReColorCell

Author(s)

Shahrbaf Mohammad Amin | Ataei Fashtami Leila | VOSOUGH MASSOUD | Issue Writer Certificate

Keywords

Cell Therapy

Keratinocyte

Melanocyte

Vitiligo

Abstract

Vitiligo is an autoimmune skin disorder that can significantly affect the quality of life in patients. However, current treatment strategies such as phototherapy, topical glucocorticosteroids, or systemic immunosuppressants can be helpful in Vitiligo management, and treatments for disease stability which is the main challenge in Vitiligo management. Novel therapeutic modalities have made promising advances in this regard. Molecular targeted therapy to target Janus-activated kinase (JAK) such as Tofacitinib and Ruxolitinib in addition to the cell-based treatments are innovative therapeutic options, which are recently used for Vitiligo treatment. Transplantation of non-cultured Melanocytes-Keratinocytes have been studied in Iran and phase one data published in 2010 on 10 patients that continued on 300 patients as phase three in 2018. Cell Tech Pharmed™,Co. registered and applied this cell-based product, ReColorCell ®, , as a GMP certified by Iranian Food and Drug Administration (IR-FDA). On 11 th December 2021, ReColorCell ®, officially registered as the first cell-based product in the Iranian drug list (IDL). Currently, the post-market study of this product is ongoing.

Cites

No record.

References

No record.

Cite

APA: Copy

Shahrbaf, Mohammad Amin, Ataei Fashtami, Leila, & VOSOUGH, MASSOUD. (2023). The First Live-Cell Based Product in The Iranian Drug List,ReColorCell. CELL JOURNAL (YAKHTEH), 25(3), 212-214. SID. https://sid.ir/paper/1038194/en

Vancouver: Copy

Shahrbaf Mohammad Amin, Ataei Fashtami Leila, VOSOUGH MASSOUD. The First Live-Cell Based Product in The Iranian Drug List,ReColorCell. CELL JOURNAL (YAKHTEH)[Internet]. 2023;25(3):212-214. Available from: https://sid.ir/paper/1038194/en

IEEE: Copy

Mohammad Amin Shahrbaf, Leila Ataei Fashtami, and MASSOUD VOSOUGH, “The First Live-Cell Based Product in The Iranian Drug List,ReColorCell,” CELL JOURNAL (YAKHTEH), vol. 25, no. 3, pp. 212–214, 2023, [Online]. Available: https://sid.ir/paper/1038194/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops